Skip to content
Monday, March 30, 2026

  • About the Jewish Review
  • Advertise
  • Contact Us
  • Home
  • Opt-out preferences
  • Terms of Use

Tag: Ranking

Teva back in top pharmaceutical rankings

April 16, 2024April 16, 2024David Rutman

After years of financial problems, downsizing, and dismissals, Israel’s multinational Teva Pharmaceutical Industries Ltd. has been named No. 19 among the top 20 best-earning pharmaceutical companies in the world. In 2022, Teva had revenues of $14.9 billion, which rose to $15.8b. last year. It has long specialized in generic drugs, but it has had some […]

Continue Reading

Recent Posts

  • Undeterred by war, North American Jews continue to immigrate to Israel March 29, 2026
  • Chicago’s new Jewish high school plucks leader from Florida day school March 27, 2026
  • Why Is Moses Not Mentioned in the Haggadah? March 27, 2026
  • Milwaukee rabbi and son ordered to pay $1,000 to muralist who reportedly praised Hamas in court March 27, 2026
  • JBBBSLA’s ‘Big Event’; AJU Taps ‘Culture Architect’ for 2050 Institute; J Los Angeles’ Program Director March 27, 2026
  • Harvard’s New Jewish Problem March 26, 2026

Categories

  • Business
  • Culture
  • Israel
  • Local
  • Opinion
  • Science and Health
  • Uncategorized
  • World News
News Vibrant | Theme: News Vibrant by CodeVibrant.